ReviewJournal of cardiothoracic surgery2026
Management strategies for non-A non-B aortic dissection: a comprehensive review.
Review in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic dissection (AD) represents a life-threatening cardiovascular emergency. The condition is traditionally classified according to the Stanford system: type A involves the ascending aorta, while type B is confined to the descending aorta. However, a small subset of cases defies this binary classification and is categorized as non-A non-B aortic dissection. These atypical presentations frequently involve the aortic arch or exhibit complex morphological features, such as retrograde extension or multi-territorial involvement, distinguishing them from classical type A or B dissections. The optimal management strategy for non-A non-B aortic dissection remains controversial. Current therapeutic approaches encompass open surgical repair, thoracic endovascular aortic repair (TEVAR), hybrid procedures, and conservative medical management. This review synthesizes the contemporary evidence regarding the epidemiology, pathophysiology, diagnostic challenges, and treatment modalities for non-A non-B aortic dissection, underscoring the critical importance of individualized management in therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.